The 4 analysts offering 12-month price forecasts for InflaRx NV have a median target of 5.58, with a high estimate of 7.10 and a low estimate of 2.03. The median estimate represents a +295.67% increase from the last price of 1.41.
The current consensus among 6 polled investment analysts is to Buy stock in InflaRx NV. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.30
Reporting Date Aug 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.